Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
41.30
-0.30 (-0.72%)
Nov 14, 2025, 5:00 PM CET
-0.72%
Market Cap758.08M
Revenue (ttm)373.90M
Net Income (ttm)465.00K
Shares Out18.36M
EPS (ttm)0.03
PE Ratio1,630.28
Forward PE98.33
Dividendn/a
Ex-Dividend Daten/a
Volume25,352
Average Volume38,305
Open41.30
Previous Close41.60
Day's Range40.80 - 42.40
52-Week Range26.50 - 56.50
Beta0.10
RSI64.49
Earnings DateNov 9, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.